Cost Of Erythropoietin Use In The Early Access Program Of Telaprevir For The Treatment Of Metavir F3-F4 Patients With Genotype 1 Hcv In Brazil

May 1, 2014, 00:00
10.1016/j.jval.2014.03.1583
https://www.valueinhealthjournal.com/article/S1098-3015(14)01634-9/fulltext
Title : Cost Of Erythropoietin Use In The Early Access Program Of Telaprevir For The Treatment Of Metavir F3-F4 Patients With Genotype 1 Hcv In Brazil
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01634-9&doi=10.1016/j.jval.2014.03.1583
First page : A272
Section Title : Infection
Open access? : No
Section Order : 1071
Categories :
Tags :
Regions :
ViH Article Tags :